前往化源商城

Infection and Immunity 2013-05-01

Interaction of Leptospira interrogans with human proteolytic systems enhances dissemination through endothelial cells and protease levels.

Monica L Vieira, Miryam P Alvarez-Flores, Karin Kirchgatter, Eliete C Romero, Ivy J Alves, Zenaide M de Morais, Silvio A Vasconcellos, Ana M Chudzinski-Tavassi, Ana L T O Nascimento

文献索引:Infect. Immun. 81(5) , 1764-74, (2013)

全文:HTML全文

摘要

We have recently reported the ability of Leptospira to capture plasminogen (PLG) and generate plasmin (PLA) bound on the microbial surface in the presence of exogenous activators. In this work, we examined the effects of leptospiral PLG binding for active penetration through the endothelial cell barrier and activation. The results indicate that leptospires with PLG association or PLA activation have enhanced migration activity through human umbilical vein endothelial cell (HUVEC) monolayers compared with untreated bacteria. Leptospira cells coated with PLG were capable of stimulating the expression of PLG activators by HUVECs. Moreover, leptospires endowed with PLG or PLA promoted transcriptional upregulation matrix metalloprotease 9 (MMP-9). Serum samples from patients with confirmed leptospirosis showed higher levels of PLG activators and total MMP-9 than serum samples from normal (healthy) subjects. The highest level of PLG activators and total MMP-9 was detected with microscopic agglutination test (MAT)-negative serum samples, suggesting that this proteolytic activity stimulation occurs at the early stage of the disease. Furthermore, a gelatin zymography profile obtained for MMPs with serum samples from patients with leptospirosis appears to be specific to leptospiral infection because serum samples from patients with unrelated infectious diseases produced no similar degradation bands. Altogether, the data suggest that the Leptospira-associated PLG or PLA might represent a mechanism that contributes to bacterial penetration of endothelial cells through an activation cascade of events that enhances the proteolytic capability of the organism. To our knowledge, this is the first proteolytic activity associated with leptospiral pathogenesis described to date.

相关化合物

结构式 名称/CAS号 全部文献
纤溶酶原 来源于人类血浆 结构式 纤溶酶原 来源于人类血浆
CAS:9001-91-6
纤维蛋白溶酶 结构式 纤维蛋白溶酶
CAS:9001-90-5